The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




Oxford Pharmascience Group PLC - OXP Initiation of Pilot Clinical Study for Naproxen
07:00 18-May-2015  RNS  0.00% View chart
Oxford Pharmascience Group PLC - OXP Ibuprofen progressing to proof of concept trial
07:22 15-May-2015  RNS  0.00% View chart
Oxford Pharmascience Group PLC - OXP PK Results for OXPzero Naproxen vs. Naprosyn
07:00 13-May-2015  RNS  0.00% View chart
Oxford Pharmascience Group PLC - OXP Successful Pilot Clinical Study
07:00 27-Mar-2015  RNS  0.00% View chart
Oxford Pharmascience Group PLC - OXP Grant of Share Options
07:00 09-Mar-2015  RNS  0.00% View chart
Oxford Pharmascience Group PLC - OXP Initiation of PK Study of OXPzeroTM Naproxen
08:32 05-Mar-2015  RNS  0.00% View chart
Oxford Pharmascience Group PLC - OXP Final Results & Notice of AGM
07:00 05-Mar-2015  RNS  0.00% View chart


RNS - regulatory news service - home


MARKET NEWS – SEARCH FEATURES

Market News is the definitive place to view real-time UK regulatory disclosures.

You will see a clear and comprehensive search, filter and sort features giving users the ability to:

  • Show only Earnings and News announcements - the default search
  • Show all announcements excluding NAVs & FRNs
  • Show all announcement types
  • See up to 500 stories per page
  • See ‘Most read news’ ticker at the top of the page
  • Select stories by Name/code, source, type, index or sector


About RNS

RNS is the London Stock Exchange's regulatory and financial communications channel for companies to communicate with the professional investor.



News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



rssRNS feeds
Allows you to be kept updated with RNS announcements.


The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds